1028332-22-0

Usage

Uses

Used in Organic Synthesis:
2,4-DICHLORO-6-HYDROXYPHENYLBORONIC ACID is used as a reagent for [its role in facilitating specific organic reactions], contributing to the synthesis of complex organic molecules and compounds.
Used in Pharmaceutical and Agrochemical Preparation:
In the Pharmaceutical Industry, 2,4-DICHLORO-6-HYDROXYPHENYLBORONIC ACID is used as a building block for [its role in the synthesis of pharmaceutical compounds], playing a crucial part in the development of new drugs and therapeutic agents.
In the Agrochemical Industry, 2,4-DICHLORO-6-HYDROXYPHENYLBORONIC ACID is used as a building block for [its role in the synthesis of agrochemicals], aiding in the creation of pesticides, herbicides, and other agricultural chemicals to enhance crop protection and yield.
Used as a Ligand in Transition Metal-Catalyzed Cross-Coupling Reactions:
2,4-DICHLORO-6-HYDROXYPHENYLBORONIC ACID is used as a ligand for [its role in stabilizing and enhancing the reactivity of transition metal catalysts], enabling efficient cross-coupling reactions that are vital for the formation of carbon-carbon and carbon-heteroatom bonds in organic synthesis.
Used in Chemical Research and Development of New Materials:
2,4-DICHLORO-6-HYDROXYPHENYLBORONIC ACID is used as a research tool for [its contribution to the understanding of chemical reactions and the development of new synthetic methods], supporting the advancement of material science and the creation of novel compounds with potential applications in various fields.

Upstream product

• 591-35-5 3,5-dichlorophenol 
• 1028332-19-5 3,5-dichloro-2-iodophenol 
• 1028332-21-9 2-(2,4-dichloro-6-(ethoxymethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1028332-20-8 1,5-dichloro-3-(ethoxymethoxy)-2-iodobenzene 

Downstream Products

• 1028332-37-7 3,5-dichloro-2-(5-(methylsulfanyl)thiazolo[5,4-d]pyrimidin-7-yl)phenol 
• 1046861-27-1 2-amino-4-(2,4-dichloro-6-hydroxyphenyl)-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid cyclobutylamide 
• 1046861-00-0 2-amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid ethylamide 
• 1207961-51-0 4-{2,4-dichloro-6-[2-(4-fluoro-pyrazol-1-yl)-ethoxy]-phenyl}-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-ylamine 
• 1047405-14-0 4-[2,4-dichloro-6-(2-(pyrazol-1-yl)ethoxy)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-ylamine 
• 1207961-52-1 2-amino-4-{2,4-dichloro-6-[2-(4-fluoro-pyrazol-1-yl)-ethoxy]-phenyl}-5,7-dihydro-pyrrolo[3,4-d]pyrimidine-6-carboxylic acid tert-butyl ester 
• 1046861-69-1 4-[2,4-dichloro-6-(2-(pyrazol-1-yl)ethoxy)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-ylamine hydrogen iodide salt 
• 1046859-32-8 2-amino-4-[2,4-dichloro-6-(2-(pyrazol-1-yl)ethoxy)phenyl]-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid ethyl ester 
• 1207961-30-5 2-amino-4-{2,4-dichloro-6-[2-(4-fluoropyrazol-1-yl)ethoxy]phenyl}-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid (2,2-difluoropropyl)amide 
• 1207961-29-2 2-amino-4-{2,4-dichloro-6-[2-(4-fluoropyrazol-1-yl)ethoxy]phenyl}-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid (2,2,2-trifluoroethyl)amide 
• 1207961-27-0 2-amino-4-{2,4-dichloro-6-[2-(4-fluoropyrazol-1-yl)ethoxy]phenyl}-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid bicyclo[1.1.1]pent-1-ylamide 
• 1207961-24-7 2-amino-4-{2,4-dichloro-6-[2-(4-chloropyrazol-1-yl)ethoxy]phenyl}-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid bicyclo[1.1.1]pent-1-ylamide 
• 1046859-65-7 2-amino-4-[2,4-dichloro-6-(2-(pyrazol-1-yl)ethoxy)phenyl]-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid (2,2-difluoropropyl)amide 
• 1046859-34-0 2-amino-4-[2,4-dichloro-6-(2-(pyrazol-1-yl)ethoxy)phenyl]-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid (2,2,2-trifluoroethyl)amide 

Relevant academic research and scientific papers

NLRP3 INFLAMMASOME INHIBITORS

The present invention relates to novel pyridazin-3-yl phenol compounds of Formula (I): wherein R1, R2, R3, R4, R5 and Z are defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammaso

Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1h- pyrazol-1-yl)ethoxy]-6-methylphenyl}-n-(2,2-difluoropropyl)-5, 7-dihydro-6h-pyrrolo[3,4-d]pyrimidine-6-carboxamide

Figure Presented. A novel class of heat shock protein 90 (Hsp90) inhibitors was discovered by high-throughput screening and was subsequently optimized using a combination of structure-based design, parallel synthesis, and the application of medicinal chemistry principles. Through this process, the biochemical and cell-based potency of the original HTS lead were substantially improved along with the corresponding metabolic stability properties. These efforts culminated with the identification of a development candidate (compound 42) which displayed desired PK/PD relationships, significant efficacy in a melanoma A2058 xenograft tumor model, and attractive DMPK profiles.

2-AMINO PYRIMIDINE COMPOUNDS AS POTENT HSP-90 INHIBITORS

The present invention is directed to compounds of formula (I), or pharmaceutically acceptable salts thereof, their synthesis, and their use as HSP-90 inhibitors.

2-AMINO PYRIDINE COMPOUNDS

The present invention is directed to 2-aminopyrimidine compounds and pharmaceutically acceptable salts thereof, their synthesis and their use as HSP-90 inhibitors.

2-AMIN0-5, 7-DIHYDR0-6H- PYRROLO [3, 4-D] PYRIMIDINE DERIVATIVES AS HSP-90 INHIBITORS FOR TREATING CANCER

The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, their synthesis, and their use as HSP-90 inhibitors.